Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zydus Cadila
Manufacturing
FDA slams 3 Indian drugmakers in flurry of recent Form 483s
The FDA hit three Indian drugmakers with Form 483s after inspections uncovered unsanitary conditions, broken equipment and poor recordkeeping.
Joseph Keenan
Apr 16, 2024 8:45am
BMS, generics companies face new suit over Revlimid 'monopoly'
Nov 22, 2022 11:38am
Tough decisions for Indian pharmas who do business with Russia
Mar 9, 2022 9:38am
Teva launches Revlimid generic, the first to do so in U.S.
Mar 7, 2022 11:11am
